APO Research
Talk to an analyst

APO RESEARCH · REPORT

Central Nervous System (CNS) Therapeutics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Central Nervous System (CNS) Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025199 pages

Choose your research edition.

Industry ResearchCentral Nervous System (CNS) Therapeutics Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Central Nervous System (CNS) Therapeutics Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Central Nervous System (CNS) Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Central Nervous System (CNS) Therapeutics Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Central Nervous System (CNS) Therapeutics Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Central Nervous System (CNS) Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Central Nervous System (CNS) Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Central Nervous System (CNS) Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Central Nervous System (CNS) Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Central Nervous System (CNS) Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Central Nervous System (CNS) Therapeutics include Biogen, UCB Pharma, Viatris, Eli Lilly, Roche, Merck & Co Inc, Novartis, Johnson and Johnson and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Central Nervous System (CNS) Therapeutics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Central Nervous System (CNS) Therapeutics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Central Nervous System (CNS) Therapeutics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Central Nervous System (CNS) Therapeutics market size, projected growth trends, production technologies, key applications, and end-use industries.

Central Nervous System (CNS) Therapeutics Segment by Company

Biogen

UCB Pharma

Viatris

Eli Lilly

Roche

Merck & Co Inc

Novartis

Johnson and Johnson

Teva

Takeda

Central Nervous System (CNS) Therapeutics Segment by Type

CNS Trauma

Neurovascular Diseases

Neurodegenerative Diseases

Other

Central Nervous System (CNS) Therapeutics Segment by Application

Hospital

Online

Other

Central Nervous System (CNS) Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Central Nervous System (CNS) Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Central Nervous System (CNS) Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Central Nervous System (CNS) Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Central Nervous System (CNS) Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Central Nervous System (CNS) Therapeutics industry.

Chapter 3: Detailed analysis of Central Nervous System (CNS) Therapeutics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Central Nervous System (CNS) Therapeuticsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Central Nervous System (CNS) Therapeutics Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of CNS Trauma Table 3. Key Players of Neurovascular Diseases Table 4. Key Players of Neurodegenerative Diseases Table 3. Key Players of Other Table 4. Global Central Nervous System (CNS) Therapeutics Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Online Table 7. Key Players of Other Table 8. Global Central Nervous System (CNS) Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Central Nervous System (CNS) Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Central Nervous System (CNS) Therapeutics Market Share by Region (2021-2026) Table 11. Global Central Nervous System (CNS) Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Central Nervous System (CNS) Therapeutics Market Share by Region (2027-2032) Table 13. Central Nervous System (CNS) Therapeutics Industry Trends Table 14. Central Nervous System (CNS) Therapeutics Industry Drivers Table 15. Central Nervous System (CNS) Therapeutics Industry Opportunities and Challenges Table 16. Central Nervous System (CNS) Therapeutics Industry Restraints Table 17. Global Central Nervous System (CNS) Therapeutics Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Central Nervous System (CNS) Therapeutics Revenue Market Share by Company (2021-2026) Table 19. Global Central Nervous System (CNS) Therapeutics Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Central Nervous System (CNS) Therapeutics Key Company Head Office and Area Served Table 21. Global Central Nervous System (CNS) Therapeutics Company, Product Type & Application Table 22. Global Central Nervous System (CNS) Therapeutics Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Central Nervous System (CNS) Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Central Nervous System (CNS) Therapeutics Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Central Nervous System (CNS) Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Central Nervous System (CNS) Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Central Nervous System (CNS) Therapeutics Revenue Market Share by Type (2021-2026) Table 29. Global Central Nervous System (CNS) Therapeutics Revenue Market Share by Type (2027-2032) Table 30. Global Central Nervous System (CNS) Therapeutics Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Central Nervous System (CNS) Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Central Nervous System (CNS) Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Central Nervous System (CNS) Therapeutics Revenue Market Share by Application (2021-2026) Table 34. Global Central Nervous System (CNS) Therapeutics Revenue Market Share by Application (2027-2032) Table 35. Biogen Company Information Table 36. Biogen Business Overview Table 37. Biogen Central Nervous System (CNS) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Biogen Central Nervous System (CNS) Therapeutics Product Portfolio Table 39. Biogen Recent Development Table 40. UCB Pharma Company Information Table 41. UCB Pharma Business Overview Table 42. UCB Pharma Central Nervous System (CNS) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. UCB Pharma Central Nervous System (CNS) Therapeutics Product Portfolio Table 44. UCB Pharma Recent Development Table 45. Viatris Company Information Table 46. Viatris Business Overview Table 47. Viatris Central Nervous System (CNS) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Viatris Central Nervous System (CNS) Therapeutics Product Portfolio Table 49. Viatris Recent Development Table 50. Eli Lilly Company Information Table 51. Eli Lilly Business Overview Table 52. Eli Lilly Central Nervous System (CNS) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Eli Lilly Central Nervous System (CNS) Therapeutics Product Portfolio Table 54. Eli Lilly Recent Development Table 55. Roche Company Information Table 56. Roche Business Overview Table 57. Roche Central Nervous System (CNS) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Roche Central Nervous System (CNS) Therapeutics Product Portfolio Table 59. Roche Recent Development Table 60. Merck & Co Inc Company Information Table 61. Merck & Co Inc Business Overview Table 62. Merck & Co Inc Central Nervous System (CNS) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Merck & Co Inc Central Nervous System (CNS) Therapeutics Product Portfolio Table 64. Merck & Co Inc Recent Development Table 65. Novartis Company Information Table 66. Novartis Business Overview Table 67. Novartis Central Nervous System (CNS) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Novartis Central Nervous System (CNS) Therapeutics Product Portfolio Table 69. Novartis Recent Development Table 70. Johnson and Johnson Company Information Table 71. Johnson and Johnson Business Overview Table 72. Johnson and Johnson Central Nervous System (CNS) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Johnson and Johnson Central Nervous System (CNS) Therapeutics Product Portfolio Table 74. Johnson and Johnson Recent Development Table 75. Teva Company Information Table 76. Teva Business Overview Table 77. Teva Central Nervous System (CNS) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Teva Central Nervous System (CNS) Therapeutics Product Portfolio Table 79. Teva Recent Development Table 80. Takeda Company Information Table 81. Takeda Business Overview Table 82. Takeda Central Nervous System (CNS) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Takeda Central Nervous System (CNS) Therapeutics Product Portfolio Table 84. Takeda Recent Development Table 85. North America Central Nervous System (CNS) Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 86. North America Central Nervous System (CNS) Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 87. North America Central Nervous System (CNS) Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 88. North America Central Nervous System (CNS) Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 89. North America Central Nervous System (CNS) Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Central Nervous System (CNS) Therapeutics Market Size by Country (2021-2026) Table 91. North America Central Nervous System (CNS) Therapeutics Market Size by Country (2027-2032) Table 92. Europe Central Nervous System (CNS) Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 93. Europe Central Nervous System (CNS) Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 94. Europe Central Nervous System (CNS) Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 95. Europe Central Nervous System (CNS) Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 96. Europe Central Nervous System (CNS) Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Central Nervous System (CNS) Therapeutics Market Size by Country (2021-2026) Table 98. Europe Central Nervous System (CNS) Therapeutics Market Size by Country (2027-2032) Table 99. China Central Nervous System (CNS) Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 100. China Central Nervous System (CNS) Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 101. China Central Nervous System (CNS) Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 102. China Central Nervous System (CNS) Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia Central Nervous System (CNS) Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 104. Asia Central Nervous System (CNS) Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 105. Asia Central Nervous System (CNS) Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 106. Asia Central Nervous System (CNS) Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 107. Asia Central Nervous System (CNS) Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Central Nervous System (CNS) Therapeutics Market Size by Country (2021-2026) Table 109. Asia Central Nervous System (CNS) Therapeutics Market Size by Country (2027-2032) Table 110. South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 111. South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 112. South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 113. South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 114. South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Country (2021-2026) Table 116. South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Country (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Central Nervous System (CNS) Therapeutics Product Image Figure 2. Global Central Nervous System (CNS) Therapeutics Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Central Nervous System (CNS) Therapeutics Market Share by Type: 2025 VS 2032 Figure 4. CNS Trauma Image Figure 5. Neurovascular Diseases Image Figure 6. Neurodegenerative Diseases Image Figure 7. Other Image Figure 8. Global Central Nervous System (CNS) Therapeutics Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Central Nervous System (CNS) Therapeutics Market Share by Application: 2025 VS 2032 Figure 10. Hospital Image Figure 11. Online Image Figure 12. Other Image Figure 13. Global Central Nervous System (CNS) Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 15. Global Central Nervous System (CNS) Therapeutics Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Central Nervous System (CNS) Therapeutics Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Central Nervous System (CNS) Therapeutics Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Central Nervous System (CNS) Therapeutics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Central Nervous System (CNS) Therapeutics Revenue Market Share by Type (2021-2032) Figure 22. Global Central Nervous System (CNS) Therapeutics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Central Nervous System (CNS) Therapeutics Revenue Market Share by Application (2021-2032) Figure 24. North America Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 25. North America Central Nervous System (CNS) Therapeutics Market Share by Type (2021-2032) Figure 26. North America Central Nervous System (CNS) Therapeutics Market Share by Application (2021-2032) Figure 27. North America Central Nervous System (CNS) Therapeutics Market Share by Country (2021-2032) Figure 28. United States Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 29. Canada Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 31. Europe Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 32. Europe Central Nervous System (CNS) Therapeutics Market Share by Type (2021-2032) Figure 33. Europe Central Nervous System (CNS) Therapeutics Market Share by Application (2021-2032) Figure 34. Europe Central Nervous System (CNS) Therapeutics Market Share by Country (2021-2032) Figure 35. Germany Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 36. France Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 38. Italy Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 39. Russia Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 41. China Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 42. China Central Nervous System (CNS) Therapeutics Market Share by Type (2021-2032) Figure 43. China Central Nervous System (CNS) Therapeutics Market Share by Application (2021-2032) Figure 44. Asia Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 45. Asia Central Nervous System (CNS) Therapeutics Market Share by Type (2021-2032) Figure 46. Asia Central Nervous System (CNS) Therapeutics Market Share by Application (2021-2032) Figure 47. Asia Central Nervous System (CNS) Therapeutics Market Share by Country (2021-2032) Figure 48. Japan Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 52. India Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 53. Australia Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Share by Country (2021-2032) Figure 58. Brazil Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 63. UAE Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 65. Chile Central Nervous System (CNS) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • CNS Trauma
  • Neurovascular Diseases
  • Neurodegenerative Diseases
  • Other
Applications
  • Hospital
  • Online
  • Other
Companies covered
  • Biogen
  • UCB Pharma
  • Viatris
  • Eli Lilly
  • Roche
  • Merck & Co Inc
  • Novartis
  • Johnson and Johnson
  • Teva
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Central Nervous System (CNS) Therapeutics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 CNS Trauma
  5. 1.2.3 Neurovascular Diseases
  6. 1.2.4 Neurodegenerative Diseases
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Central Nervous System (CNS) Therapeutics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Online
  12. 1.3.4 Other
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Central Nervous System (CNS) Therapeutics Growth Trends by Region
  15. 1.5.1 Global Central Nervous System (CNS) Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Central Nervous System (CNS) Therapeutics Market Size by Region (2021-2026)
  17. 1.5.3 Central Nervous System (CNS) Therapeutics Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Central Nervous System (CNS) Therapeutics Market Dynamics
  1. 2.1 Central Nervous System (CNS) Therapeutics Industry Trends
  2. 2.2 Central Nervous System (CNS) Therapeutics Industry Drivers
  3. 2.3 Central Nervous System (CNS) Therapeutics Industry Opportunities and Challenges
  4. 2.4 Central Nervous System (CNS) Therapeutics Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Central Nervous System (CNS) Therapeutics Revenue by Company (2021-2026)
  2. 3.2 Global Central Nervous System (CNS) Therapeutics Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Central Nervous System (CNS) Therapeutics Key Company Head office and Area Served
  4. 3.4 Global Central Nervous System (CNS) Therapeutics Company, Product Type & Application
  5. 3.5 Global Central Nervous System (CNS) Therapeutics Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Central Nervous System (CNS) Therapeutics Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Central Nervous System (CNS) Therapeutics Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Central Nervous System (CNS) Therapeutics Tier 1, Tier 2, and Tier 3
4 Central Nervous System (CNS) Therapeutics Market by Type
  1. 4.1 Global Central Nervous System (CNS) Therapeutics Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Central Nervous System (CNS) Therapeutics Market Size by Type (2021-2032)
  3. 4.3 Global Central Nervous System (CNS) Therapeutics Market Size Share by Type (2021-2032)
5 Central Nervous System (CNS) Therapeutics Market by Application
  1. 5.1 Global Central Nervous System (CNS) Therapeutics Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Central Nervous System (CNS) Therapeutics Market Size by Application (2021-2032)
  3. 5.3 Global Central Nervous System (CNS) Therapeutics Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Biogen
  2. 6.1.1 Biogen Company Information
  3. 6.1.2 Biogen Business Overview
  4. 6.1.3 Biogen Central Nervous System (CNS) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Biogen Central Nervous System (CNS) Therapeutics Product Portfolio
  6. 6.1.5 Biogen Recent Developments
  7. 6.2 UCB Pharma
  8. 6.2.1 UCB Pharma Company Information
  9. 6.2.2 UCB Pharma Business Overview
  10. 6.2.3 UCB Pharma Central Nervous System (CNS) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 UCB Pharma Central Nervous System (CNS) Therapeutics Product Portfolio
  12. 6.2.5 UCB Pharma Recent Developments
  13. 6.3 Viatris
  14. 6.3.1 Viatris Company Information
  15. 6.3.2 Viatris Business Overview
  16. 6.3.3 Viatris Central Nervous System (CNS) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Viatris Central Nervous System (CNS) Therapeutics Product Portfolio
  18. 6.3.5 Viatris Recent Developments
  19. 6.4 Eli Lilly
  20. 6.4.1 Eli Lilly Company Information
  21. 6.4.2 Eli Lilly Business Overview
  22. 6.4.3 Eli Lilly Central Nervous System (CNS) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Eli Lilly Central Nervous System (CNS) Therapeutics Product Portfolio
  24. 6.4.5 Eli Lilly Recent Developments
  25. 6.5 Roche
  26. 6.5.1 Roche Company Information
  27. 6.5.2 Roche Business Overview
  28. 6.5.3 Roche Central Nervous System (CNS) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Roche Central Nervous System (CNS) Therapeutics Product Portfolio
  30. 6.5.5 Roche Recent Developments
  31. 6.6 Merck & Co Inc
  32. 6.6.1 Merck & Co Inc Company Information
  33. 6.6.2 Merck & Co Inc Business Overview
  34. 6.6.3 Merck & Co Inc Central Nervous System (CNS) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Merck & Co Inc Central Nervous System (CNS) Therapeutics Product Portfolio
  36. 6.6.5 Merck & Co Inc Recent Developments
  37. 6.7 Novartis
  38. 6.7.1 Novartis Company Information
  39. 6.7.2 Novartis Business Overview
  40. 6.7.3 Novartis Central Nervous System (CNS) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Novartis Central Nervous System (CNS) Therapeutics Product Portfolio
  42. 6.7.5 Novartis Recent Developments
  43. 6.8 Johnson and Johnson
  44. 6.8.1 Johnson and Johnson Company Information
  45. 6.8.2 Johnson and Johnson Business Overview
  46. 6.8.3 Johnson and Johnson Central Nervous System (CNS) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Johnson and Johnson Central Nervous System (CNS) Therapeutics Product Portfolio
  48. 6.8.5 Johnson and Johnson Recent Developments
  49. 6.9 Teva
  50. 6.9.1 Teva Company Information
  51. 6.9.2 Teva Business Overview
  52. 6.9.3 Teva Central Nervous System (CNS) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Teva Central Nervous System (CNS) Therapeutics Product Portfolio
  54. 6.9.5 Teva Recent Developments
  55. 6.10 Takeda
  56. 6.10.1 Takeda Company Information
  57. 6.10.2 Takeda Business Overview
  58. 6.10.3 Takeda Central Nervous System (CNS) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Takeda Central Nervous System (CNS) Therapeutics Product Portfolio
  60. 6.10.5 Takeda Recent Developments
7 North America
  1. 7.1 North America Central Nervous System (CNS) Therapeutics Market Size (2021-2032)
  2. 7.2 North America Central Nervous System (CNS) Therapeutics Market Size by Type
  3. 7.2.1 North America Central Nervous System (CNS) Therapeutics Market Size by Type (2021-2026)
  4. 7.2.2 North America Central Nervous System (CNS) Therapeutics Market Size by Type (2027-2032)
  5. 7.2.3 North America Central Nervous System (CNS) Therapeutics Market Share by Type (2021-2032)
  6. 7.3 North America Central Nervous System (CNS) Therapeutics Market Size by Application
  7. 7.3.1 North America Central Nervous System (CNS) Therapeutics Market Size by Application (2021-2026)
  8. 7.3.2 North America Central Nervous System (CNS) Therapeutics Market Size by Application (2027-2032)
  9. 7.3.3 North America Central Nervous System (CNS) Therapeutics Market Share by Application (2021-2032)
  10. 7.4 North America Central Nervous System (CNS) Therapeutics Market Size by Country
  11. 7.4.1 North America Central Nervous System (CNS) Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Central Nervous System (CNS) Therapeutics Market Size by Country (2021-2026)
  13. 7.4.3 North America Central Nervous System (CNS) Therapeutics Market Size by Country (2027-2032)
  14. 7.4.4 North America Central Nervous System (CNS) Therapeutics Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Central Nervous System (CNS) Therapeutics Market Size (2021-2032)
  2. 8.2 Europe Central Nervous System (CNS) Therapeutics Market Size by Type
  3. 8.2.1 Europe Central Nervous System (CNS) Therapeutics Market Size by Type (2021-2026)
  4. 8.2.2 Europe Central Nervous System (CNS) Therapeutics Market Size by Type (2027-2032)
  5. 8.2.3 Europe Central Nervous System (CNS) Therapeutics Market Share by Type (2021-2032)
  6. 8.3 Europe Central Nervous System (CNS) Therapeutics Market Size by Application
  7. 8.3.1 Europe Central Nervous System (CNS) Therapeutics Market Size by Application (2021-2026)
  8. 8.3.2 Europe Central Nervous System (CNS) Therapeutics Market Size by Application (2027-2032)
  9. 8.3.3 Europe Central Nervous System (CNS) Therapeutics Market Share by Application (2021-2032)
  10. 8.4 Europe Central Nervous System (CNS) Therapeutics Market Size by Country
  11. 8.4.1 Europe Central Nervous System (CNS) Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Central Nervous System (CNS) Therapeutics Market Size by Country (2021-2026)
  13. 8.4.3 Europe Central Nervous System (CNS) Therapeutics Market Size by Country (2027-2032)
  14. 8.4.4 Europe Central Nervous System (CNS) Therapeutics Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Central Nervous System (CNS) Therapeutics Market Size (2021-2032)
  2. 9.2 China Central Nervous System (CNS) Therapeutics Market Size by Type
  3. 9.2.1 China Central Nervous System (CNS) Therapeutics Market Size by Type (2021-2026)
  4. 9.2.2 China Central Nervous System (CNS) Therapeutics Market Size by Type (2027-2032)
  5. 9.2.3 China Central Nervous System (CNS) Therapeutics Market Share by Type (2021-2032)
  6. 9.3 China Central Nervous System (CNS) Therapeutics Market Size by Application
  7. 9.3.1 China Central Nervous System (CNS) Therapeutics Market Size by Application (2021-2026)
  8. 9.3.2 China Central Nervous System (CNS) Therapeutics Market Size by Application (2027-2032)
  9. 9.3.3 China Central Nervous System (CNS) Therapeutics Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Central Nervous System (CNS) Therapeutics Market Size (2021-2032)
  2. 10.2 Asia Central Nervous System (CNS) Therapeutics Market Size by Type
  3. 10.2.1 Asia Central Nervous System (CNS) Therapeutics Market Size by Type (2021-2026)
  4. 10.2.2 Asia Central Nervous System (CNS) Therapeutics Market Size by Type (2027-2032)
  5. 10.2.3 Asia Central Nervous System (CNS) Therapeutics Market Share by Type (2021-2032)
  6. 10.3 Asia Central Nervous System (CNS) Therapeutics Market Size by Application
  7. 10.3.1 Asia Central Nervous System (CNS) Therapeutics Market Size by Application (2021-2026)
  8. 10.3.2 Asia Central Nervous System (CNS) Therapeutics Market Size by Application (2027-2032)
  9. 10.3.3 Asia Central Nervous System (CNS) Therapeutics Market Share by Application (2021-2032)
  10. 10.4 Asia Central Nervous System (CNS) Therapeutics Market Size by Country
  11. 10.4.1 Asia Central Nervous System (CNS) Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Central Nervous System (CNS) Therapeutics Market Size by Country (2021-2026)
  13. 10.4.3 Asia Central Nervous System (CNS) Therapeutics Market Size by Country (2027-2032)
  14. 10.4.4 Asia Central Nervous System (CNS) Therapeutics Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Central Nervous System (CNS) Therapeutics Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst